The partnership with NED Medical to develop ceramic-based microspheres for cancer treatment is a significant advancement for SINTX Technologies. This collaboration could enhance SINTX's product offerings and market position in the medical field, potentially leading to positive investor sentiment and a short-term stock price increase.